Today, the presidents of Senegal, Rwanda and Ghana, as well as WHO general director Tedros Ghebreyesus, travelled to Marburg for the latest BioNTech product launch. There they all posed for photos with the vaccine tycoon and BioNTech CEO Özlem Türeci, while he introduced them to the BioNTainer, a semi-mobile vaccine factory cobbled together out of six shipping containers. The message: Africa will be a vaccine importer no longer. Soon, Africans will get their own factories, just like we have here. When it’s finally up and running, each BioNTainer will be capable of churning out up to 50 million doses a year!
Well, kind of. Actually, probably not. Reuters reports that the BioNTainers “will require a hall of about 800 square metres,” as well as (of course) local infrastructure and local quality control testing laboratories – all of which the host countries will have to supply. In other words, these aren’t mobile factories at all; they’re just containers full of laboratory equipment with cool green lighting and an emergency eyewash station.
Also too, these wunderlabs will have to be staffed BioNTech personnel, until the company can train “local partners to take over the complex vaccine making procedure,” and production won’t begin until the middle of 2023.
It does not take a genius to figure out what is going on here. On the one hand, something like less than 15% of Africa is fully vaccinated, which is a bad look for globalist politicians who want to blame the continued existence of SARS-2 on tiny unvaccinated first-world minorities. On the other hand, the EU and Germany continue to defend BioNTech’s vaccine patents before the World Trade Organisation, betraying to all and sundry that there are indeed more important things than lipid nanoparticles in every bloodstream.
